Patrick Frost, PhD

Patrick Frost, PhD

Feb 02, 2016

Group 6 Copy 59
-2
Please wait...

About This Project

BBRI and Los Angeles VA Medical Center

Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.

Blast off!

Browse Other Projects on Experiment

Related Projects

An initial exploration of in-situ underwater genetic sequencing

Our goal is to adapt portable genome sequencing technology for high-pressure, underwater environments. Currently...

Making Moorit: Determining the Molecular Basis for Brown Colored Sheep

Sheep come in a variety of different patterns and colors, with black or white individuals being the most...

Can intensive forestry benefit the threatened Rusty Blackbird?

The Rusty Blackbird is a globally threatened North American songbird that has declined precipitously over...

Backer Badge Funded